0001104659-22-084765.txt : 20220801
0001104659-22-084765.hdr.sgml : 20220801
20220801170341
ACCESSION NUMBER: 0001104659-22-084765
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220728
FILED AS OF DATE: 20220801
DATE AS OF CHANGE: 20220801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENNEMAN JOHN B III
CENTRAL INDEX KEY: 0001187572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 221125620
MAIL ADDRESS:
STREET 1: 311 C ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
tm2222147-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-07-28
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001187572
HENNEMAN JOHN B III
535 BOYLSTON STREET
BOSTON
MA
02116
1
0
0
0
Common Stock
2022-07-28
4
A
0
5995
0
A
15605
D
Stock Option (right to Buy)
1.09
2022-07-28
4
A
0
29575
0
A
2032-07-28
Common Stock
29575
29575
D
These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023,
subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to
acceleration under certain conditions.
The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the
applicable vesting date and subject to acceleration under certain conditions.
/s/ Scott M. Coiante, attorney-in-fact
2022-08-01